GenMont Biotech Incorporation reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 76.08 million compared to TWD 105.37 million a year ago. Net income was TWD 8.12 million compared to TWD 23.56 million a year ago. Basic earnings per share was TWD 0.09 compared to TWD 0.27 a year ago. Diluted earnings per share was TWD 0.09 compared to TWD 0.27 a year ago.
For the nine months, sales was TWD 262.53 million compared to TWD 308.61 million a year ago. Net income was TWD 43.13 million compared to TWD 68.91 million a year ago. Basic earnings per share was TWD 0.5 compared to TWD 0.8 a year ago. Diluted earnings per share was TWD 0.5 compared to TWD 0.79 a year ago.